C
Elevated LDL cholesterol
Lipids & LipoproteinsLab test / biomarkerriskmodifiable
11
evidence score
Also known as: elevated LDL-C levels
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 3meta-analyses: 0trials: 7.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviewsClinical trials (5)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT06597006 | Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol | RECRUITING | INTERVENTIONAL | Inclisiran, Placebo |
| NCT05614219 | Can Biochemistry Interpretive Comments on Elevated Cholesterol Levels, Increase Referrals to Lipid Clinics and Detection Rate of Familial Hypercholesterolemia? A Step Wedge Cluster Randomized Controlled Trial. | RECRUITING | INTERVENTIONAL | Biochemistry interpretive comment on elevated LDL-C levels |
| NCT01959971 | A Phase 1 Study of the Effects of Subcutaneous Doses of Alirocumab on Lipid and Lipoprotein Metabolism in Adults With Mildly Elevated LDL-Cholesterol | COMPLETED | INTERVENTIONAL | alirocumab, Placebo |
| NCT01004705 | Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Study of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril in Subjects With Elevated LDL Cholesterol | TERMINATED | INTERVENTIONAL | Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),, Simvastatin |
| NCT00529542 | A Six-week Double Blinded, Randomized Trial of Atorvastatin for the Treatment of PCOS Women With Elevated LDL Cholesterol | COMPLETED | INTERVENTIONAL | Lipitor, Placebo |
Genetic associations (0)
None linked.